
11 - 50 employees
Founded 2017
🧬 Biotechnology
⚕️ Healthcare Insurance
💊 Pharmaceuticals
Biotechnology • Healthcare Insurance • Pharmaceuticals
Protara Therapeutics is a biopharmaceutical company dedicated to developing transformative therapies for patients with rare diseases and significant unmet medical needs. The company's lead investigational product, TARA-002, is a cell therapy designed for the treatment of non-muscle invasive bladder cancer and lymphatic malformations, and has received Rare Pediatric Disease Designation from the FDA. Additionally, Protara is working on IV Choline Chloride, an innovative therapy for patients requiring parenteral support who are deficient in choline.
🕒 Yesterday
Medical Science Liaison for Protara Therapeutics engaging healthcare professionals to provide support for cancer and rare diseases. Focus on building relationships and facilitating information exchange.
🕒 April 10
Executive Director managing Market Access for Protara Therapeutics, focusing on distribution models in oncology and rare diseases. Oversee collaborations with channel partners and ensure compliance across networks.